{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:25:36Z","timestamp":1773285936291,"version":"3.50.1"},"reference-count":43,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The interleukin-6 (IL-6) cytokine family plays an important role in regulating cellular responses during hematopoiesis. We report here that mice homozygous for a knock-in mutation in the IL-6 cytokine family receptor signaling subunit glycoprotein (gp) 130 (gp130Y757F\/Y757F) that leads to gp130-dependent signal transducers and activators of transcription (STAT) 1\/3 hyperactivation develop a broad spectrum of hematopoietic abnormalities, including splenomegaly, lymphadenopathy, and thrombocytosis. To determine whether STAT3 hyperactivation was responsible for the perturbed hematopoiesis in gp130Y757F\/Y757F mice, we generated gp130Y757F\/Y757F mice on a Stat3 heterozygous (Stat3+\/-) background to specifically reduce gp130-dependent activation of STAT3, but not STAT1. Normal hematopoiesis was observed in gp130Y757F\/Y757F:Stat3+\/- bone marrow and spleen, with no evidence of the splenomegaly and thrombocytosis displayed by gp130Y757F\/Y757F mice. The perturbed cellular composition of thymus and lymph nodes in gp130Y757F\/Y757F mice was also alleviated in gp130Y757F\/Y757F: Stat3+\/- mice. Furthermore, we show that hematopoietic cells from gp130Y757F\/Y757F mice exhibited increased survival and proliferation in response to IL-6 family cytokines. Collectively, these data provide genetic evidence that gp130-dependent STAT3 hyperactivation during hematopoiesis has pathological consequences affecting multiple organs, and therefore identify the threshold of STAT3 signaling elicited by IL-6 family cytokines as a critical determinant for hematopoietic homeostasis.<\/jats:p>","DOI":"10.1182\/blood-2004-09-3751","type":"journal-article","created":{"date-parts":[[2005,1,14]],"date-time":"2005-01-14T01:29:44Z","timestamp":1105666184000},"page":"3512-3520","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":65,"title":["The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis"],"prefix":"10.1182","volume":"105","author":[{"given":"Brendan J.","family":"Jenkins","sequence":"first","affiliation":[{"name":"From the Ludwig Institute for Cancer Research, Colon Molecular and Cell Biology Laboratory; and Division of Cancer and Haematology, The Walter and Eliza Hall Institute for Medical Research, Royal Melbourne Hospital, Parkville, Victoria, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew W.","family":"Roberts","sequence":"additional","affiliation":[{"name":"From the Ludwig Institute for Cancer Research, Colon Molecular and Cell Biology Laboratory; and Division of Cancer and Haematology, The Walter and Eliza Hall Institute for Medical Research, Royal Melbourne Hospital, Parkville, Victoria, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meri","family":"Najdovska","sequence":"additional","affiliation":[{"name":"From the Ludwig Institute for Cancer Research, Colon Molecular and Cell Biology Laboratory; and Division of Cancer and Haematology, The Walter and Eliza Hall Institute for Medical Research, Royal Melbourne Hospital, Parkville, Victoria, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianne","family":"Grail","sequence":"additional","affiliation":[{"name":"From the Ludwig Institute for Cancer Research, Colon Molecular and Cell Biology Laboratory; and Division of Cancer and Haematology, The Walter and Eliza Hall Institute for Medical Research, Royal Melbourne Hospital, Parkville, Victoria, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Ernst","sequence":"additional","affiliation":[{"name":"From the Ludwig Institute for Cancer Research, Colon Molecular and Cell Biology Laboratory; and Division of Cancer and Haematology, The Walter and Eliza Hall Institute for Medical Research, Royal Melbourne Hospital, Parkville, Victoria, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021223492157400_REF1","doi-asserted-by":"crossref","unstructured":"Peters M, Muller AM, Rose-John S. Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Blood. 1998;92: 3495-3504.","DOI":"10.1182\/blood.V92.10.3495"},{"key":"2020021223492157400_REF2","doi-asserted-by":"crossref","unstructured":"Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood. 1995;86: 1243-1254.","DOI":"10.1182\/blood.V86.4.1243.bloodjournal8641243"},{"key":"2020021223492157400_REF3","doi-asserted-by":"crossref","unstructured":"Yoshida K, Taga T, Saito M, et al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A. 1996;93: 407-411.","DOI":"10.1073\/pnas.93.1.407"},{"key":"2020021223492157400_REF4","doi-asserted-by":"crossref","unstructured":"Escary JL, Perreau J, Dumenil D, Ezine S, Brulet P. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature. 1993;363: 361-364.","DOI":"10.1038\/363361a0"},{"key":"2020021223492157400_","doi-asserted-by":"crossref","unstructured":"Bernad A, Kopf M, Kulbacki R, Weich N, Koehler G, Gutierrez-Ramos JC. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity. 1994;1: 725-731.","DOI":"10.1016\/S1074-7613(94)80014-6"},{"key":"2020021223492157400_REF6","doi-asserted-by":"crossref","unstructured":"Ware CB, Horowitz MC, Renshaw BR, et al. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development. 1995;121: 1283-1299.","DOI":"10.1242\/dev.121.5.1283"},{"key":"2020021223492157400_REF7","doi-asserted-by":"crossref","unstructured":"Shen MM, Skoda RC, Cardiff RD, Campos-Torres J, Leder P, Ornitz DM. Expression of LIF in transgenic mice results in altered thymic epithelium and apparent interconversion of thymic and lymph node morphologies. EMBO J. 1994;13: 1375-1385.","DOI":"10.1002\/j.1460-2075.1994.tb06391.x"},{"key":"2020021223492157400_REF8","doi-asserted-by":"crossref","unstructured":"Peters M, Schirmacher P, Goldschmitt J, et al. Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice. J Exp Med. 1997;185: 755-766.","DOI":"10.1084\/jem.185.4.755"},{"key":"2020021223492157400_REF9","doi-asserted-by":"crossref","unstructured":"Hilton DJ, Hilton AA, Raicevic A, et al. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 1994;13: 4765-4775.","DOI":"10.1002\/j.1460-2075.1994.tb06802.x"},{"key":"2020021223492157400_REF10","doi-asserted-by":"crossref","unstructured":"Murakami M, Hibi M, Nakagawa N, et al. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science. 1993;260: 1808-1810.","DOI":"10.1126\/science.8511589"},{"key":"2020021223492157400_REF11","doi-asserted-by":"crossref","unstructured":"Gearing DP, Thut CJ, VandeBos T, et al. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 1991;10: 2839-2848.","DOI":"10.1002\/j.1460-2075.1991.tb07833.x"},{"key":"2020021223492157400_REF12","doi-asserted-by":"crossref","unstructured":"Mosley B, De Imus C, Friend D, et al. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem. 1996;271: 32635-32643.","DOI":"10.1074\/jbc.271.51.32635"},{"key":"2020021223492157400_REF13","doi-asserted-by":"crossref","unstructured":"Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signaling through the gp130\/Jak\/STAT pathway. Biochem J. 1998;334: 297-314.","DOI":"10.1042\/bj3340297"},{"key":"2020021223492157400_REF14","doi-asserted-by":"crossref","unstructured":"Gerhartz C, Heesel B, Sasse J, et al. Differential activation of acute phase response factor\/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130, I: definition of a novel phosphotyrosine motif mediating STAT1 activation. J Biol Chem. 1996;271: 12991-12998.","DOI":"10.1074\/jbc.271.22.12991"},{"key":"2020021223492157400_REF15","doi-asserted-by":"crossref","unstructured":"Nicholson SE, De Souza D, Fabri LJ, et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci U S A. 2000;97: 6493-6498.","DOI":"10.1073\/pnas.100135197"},{"key":"2020021223492157400_REF16","doi-asserted-by":"crossref","unstructured":"Takahashi-Tezuka M, Yoshida Y, Fukada T, et al. Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol Cell Biol. 1998;18: 4109-4117.","DOI":"10.1128\/MCB.18.7.4109"},{"key":"2020021223492157400_REF17","doi-asserted-by":"crossref","unstructured":"Tebbutt NC, Giraud A, Inglese M, et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med. 2002;8: 1089-1097.","DOI":"10.1038\/nm763"},{"key":"2020021223492157400_REF18","doi-asserted-by":"crossref","unstructured":"Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell Jr JE, Yancopoulos GD. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science. 1995;267: 1349-1353.","DOI":"10.1126\/science.7871433"},{"key":"2020021223492157400_REF19","doi-asserted-by":"crossref","unstructured":"Lehmann U, Schmitz J, Weissenbach M, et al. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130. J Biol Chem. 2003;278: 661-671.","DOI":"10.1074\/jbc.M210552200"},{"key":"2020021223492157400_REF20","doi-asserted-by":"crossref","unstructured":"Krebs DL, Hilton DJ. SOCS proteins: negative regulators of cytokine signaling. Stem Cells. 2001;19: 378-387.","DOI":"10.1634\/stemcells.19-5-378"},{"key":"2020021223492157400_REF21","doi-asserted-by":"crossref","unstructured":"Auernhammer CJ, Bousquet C, Melmed S. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci U S A. 1999;96: 6964-6969.","DOI":"10.1073\/pnas.96.12.6964"},{"key":"2020021223492157400_REF22","doi-asserted-by":"crossref","unstructured":"Lee CK, Raz R, Gimeno R, et al. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity. 2002;17: 63-72.","DOI":"10.1016\/S1074-7613(02)00336-9"},{"key":"2020021223492157400_REF23","doi-asserted-by":"crossref","unstructured":"Ohtani T, Ishihara K, Atsumi T, et al. Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. Immunity. 2000;12: 95-105.","DOI":"10.1016\/S1074-7613(00)80162-4"},{"key":"2020021223492157400_REF24","doi-asserted-by":"crossref","unstructured":"Ernst M, Jenkins BJ. Acquiring signaling specificity from the cytokine receptor gp130. Trends Genet. 2004;20: 23-32.","DOI":"10.1016\/j.tig.2003.11.003"},{"key":"2020021223492157400_REF25","doi-asserted-by":"crossref","unstructured":"Takeda K, Kaisho T, Yoshida N, Takeda J, Kishimoto T, Akira S. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol. 1998;161: 4652-4660.","DOI":"10.4049\/jimmunol.161.9.4652"},{"key":"2020021223492157400_REF26","doi-asserted-by":"crossref","unstructured":"Welte T, Zhang S, Wang T, et al. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci U S A. 2003;100: 1879-1884.","DOI":"10.1073\/pnas.0237137100"},{"key":"2020021223492157400_REF27","doi-asserted-by":"crossref","unstructured":"Benekli M, Baer MR, Baumann H, Wetzler M. Signal transducer and activator of transcription proteins in leukemias. Blood. 2003;101: 2940-2954.","DOI":"10.1182\/blood-2002-04-1204"},{"key":"2020021223492157400_REF28","doi-asserted-by":"crossref","unstructured":"Jenkins BJ, Quilici C, Roberts AW, Grail D, Dunn AR, Ernst M. Hematopoietic abnormalities in mice deficient in gp130-mediated STAT signaling. Exp Hematol. 2002;30: 1248-1256.","DOI":"10.1016\/S0301-472X(02)00929-3"},{"key":"2020021223492157400_REF29","doi-asserted-by":"crossref","unstructured":"Takeda K, Noguchi K, Shi W, et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A. 1997;94: 3801-3804.","DOI":"10.1073\/pnas.94.8.3801"},{"key":"2020021223492157400_REF30","doi-asserted-by":"crossref","unstructured":"Jenkins BJ, Grail D, Inglese M, et al. Imbalanced gp130-dependent signaling in macrophages alters macrophage colony-stimulating factor responsiveness via regulation of c-fms expression. Mol Cell Biol. 2004;24: 1453-1463.","DOI":"10.1128\/MCB.24.4.1453-1463.2004"},{"key":"2020021223492157400_REF31","doi-asserted-by":"crossref","unstructured":"Wen Z, Zhong Z, Darnell Jr JE. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 1995;82: 241-250.","DOI":"10.1016\/0092-8674(95)90311-9"},{"key":"2020021223492157400_REF32","doi-asserted-by":"crossref","unstructured":"Maritano D, Sugrue ML, Tininini S, et al. The STAT3 isoforms alpha and beta have unique and specific functions. Nat Immunol. 2004;5: 401-409.","DOI":"10.1038\/ni1052"},{"key":"2020021223492157400_REF33","doi-asserted-by":"crossref","unstructured":"Levy DE, Lee CK. What does Stat3 do? J Clin Invest. 2002;109: 1143-1148.","DOI":"10.1172\/JCI0215650"},{"key":"2020021223492157400_REF34","doi-asserted-by":"crossref","unstructured":"Croker BA, Metcalf D, Robb L, et al. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity. 2004;20: 153-165.","DOI":"10.1016\/S1074-7613(04)00022-6"},{"key":"2020021223492157400_REF35","doi-asserted-by":"crossref","unstructured":"Croker BA, Krebs DL, Zhang JG, et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol. 2003;4: 540-545.","DOI":"10.1038\/ni931"},{"key":"2020021223492157400_REF36","unstructured":"Ishibashi T, Shikama Y, Kimura H, et al. Thrombopoietic effects of interleukin-6 in long-term administration in mice. Exp Hematol. 1993;21: 640-646."},{"key":"2020021223492157400_REF37","doi-asserted-by":"crossref","unstructured":"Leonard JP, Quinto CM, Kozitza MK, Neben TY, Goldman SJ. Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood. 1994;83: 1499-1506.","DOI":"10.1182\/blood.V83.6.1499.bloodjournal8361499"},{"key":"2020021223492157400_REF38","doi-asserted-by":"crossref","unstructured":"Neben TY, Loebelenz J, Hayes L, et al. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood. 1993;81: 901-908.","DOI":"10.1182\/blood.V81.4.901.901"},{"key":"2020021223492157400_REF39","doi-asserted-by":"crossref","unstructured":"Miller CL, Eaves CJ. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. Proc Natl Acad Sci U S A. 1997;94: 13648-13653.","DOI":"10.1073\/pnas.94.25.13648"},{"key":"2020021223492157400_REF40","doi-asserted-by":"crossref","unstructured":"Tajima S, Tsuji K, Ebihara Y, et al. Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells. J Exp Med. 1996;184: 1357-1364.","DOI":"10.1084\/jem.184.4.1357"},{"key":"2020021223492157400_REF41","doi-asserted-by":"crossref","unstructured":"Audet J, Miller CL, Rose-John S, Piret JM, Eaves CJ. Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells. Proc Natl Acad Sci U S A. 2001;98: 1757-1762.","DOI":"10.1073\/pnas.98.4.1757"},{"key":"2020021223492157400_REF42","doi-asserted-by":"crossref","unstructured":"Oh IH, Eaves CJ. Overexpression of a dominant negative form of STAT3 selectively impairs hematopoietic stem cell activity. Oncogene. 2002;21: 4778-4787.","DOI":"10.1038\/sj.onc.1205592"},{"key":"2020021223492157400_REF43","doi-asserted-by":"crossref","unstructured":"Matsuda T, Nakamura T, Nakao K, et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 1999;18: 4261-4269.","DOI":"10.1093\/emboj\/18.15.4261"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/9\/3512\/1709928\/zh800905003512.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/9\/3512\/1709928\/zh800905003512.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T15:26:52Z","timestamp":1682954812000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/9\/3512\/21269\/The-threshold-of-gp130dependent-STAT3-signaling-is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-09-3751","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,1]]}}}